FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

MODIFICATION TO REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTATIVE TEST KIT

K Number: K024195 · Decision Jan 3, 2003
Classifications
1
FEI Numbers
25
Registration Numbers
25
Same Product Code
93
Applicant Total
23
Review Days
14

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
MODIFICATION TO REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTATIVE TEST KIT
K Number
K024195
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
866.5660
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Statement
Applicant
Corgenix, Inc.
Date Received
December 20, 2002
Decision Date
January 3, 2003
Product Code
MID
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MID System, Test, Anticardiolipin Immunological

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (MID), ordered by most recent decision date.

View all

Other Clearances by Corgenix, Inc.

K Number Device Name
K072032 IGG ANTI-ATHEROX TEST KIT
K062025 ASPIRINWORKS TEST KIT (11-DEHYDRO THROMBOXANE B2), MODEL 12136
K042680 RHIGENE HEP-ANA TEST SYSTEM
K032139 REAADS VON WILLEBRAND FACTOR ACTIVITY TEST KIT, MODEL 10826
K034013 REAADS DSDNA QUANTITATIVE TEST KIT, MODEL 022-001
K032868 REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139
K031208 REAADS IGM ANTI-B2GPI TEST KIT, MODEL 038-001
K024196 REEADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KIT
K022990 REAADS IGA ANTI-CARDIOLIPIN SEMI-QUANTITATIVE TEST KIT, MODEL 026-001
K022992 REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001
Search all 23 clearances from Corgenix, Inc. →